Semnur Pharmaceuticals, Inc.
SMNRW- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001913577
No open-market purchases or sales by Semnur Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesSMNR
13F holders, Q3 2022
Institutional positions in Semnur Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +12 vs. Q2 2022
- Shares held
- 7.14M
- +2.24M (+45.7%) vs. Q2 2022
- Total value
- $486.1K
- +$46.1K (+10.5%) vs. Q2 2022
- New holders
- 12
- 1 more added
- Sold out
- 0
- 2 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SMNRW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 3 | $59.8K |
| Q1 2025 | 19 | $319.8K |
| Q4 2024 | 19 | $213.6K |
| Q3 2024 | 22 | $343.3K |
| Q2 2024 | 20 | $107.8K |
| Q1 2024 | 25 | $279.6K |
| Q4 2023 | 28 | $321.3K |
| Q3 2023 | 29 | $435.8K |
| Q2 2023 | 27 | $381.8K |
| Q1 2023 | 28 | $421.2K |
| Q4 2022 | 25 | $244.2K |
| Q3 2022 | 25 | $486.1K |
| Q2 2022 | 13 | $440.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Semnur Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 1,400,000 | $98.0K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 605,000 | $51.0K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 573,900 | $40.0K | 0.00% | +573,900 | New |
| Hudson Bay Capital Management LP | 465,000 | $37.0K | 0.00% | −35,000−7.0% | Reduced |
| Saba Capital Management, L.P. | 410,000 | $35.0K | 0.00% | 00.0% | Unchanged |
| Atw Spac Management LLC | 470,000 | $33.0K | 0.01% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 393,423 | $28.0K | 0.00% | +393,423 | New |
| Taconic Capital Advisors LP | 257,500 | $26.0K | 0.00% | 00.0% | Unchanged |
| Arena Investors LP | 225,000 | $19.1K | 0.01% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 225,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 199,500 | $17.0K | 0.00% | +199,500 | New |
| Whitebox Advisors LLC | 200,000 | $14.0K | 0.00% | +200,000 | New |
| Ionic Capital Management LLC | 150,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 168,412 | $12.0K | 0.00% | +168,412 | New |
| Wolverine Asset Management LLC | 162,419 | $11.0K | 0.00% | +162,419 | New |
| Lynwood Capital Management Inc. | 104,500 | $7.00K | 0.01% | −500−0.5% | Reduced |
| Clear Street LLC | 97,872 | $7.00K | 0.00% | +65,862+205.8% | Added |
| Fifth Lane Capital, LP | 72,500 | $6.00K | 0.00% | +72,500 | New |
| CVI Holdings, LLC | 50,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 64,208 | $4.00K | 0.00% | +64,208 | New |
| Spartan Fund Management Inc. | 60,000 | $4.00K | 0.00% | +60,000 | New |
| Susquehanna International Group, LLP | 17,800 | $1.00K | 0.00% | +17,800 | New |
| Exos TFP Holdings LLC | 15,902 | $1.00K | 0.00% | +15,902 | New |
| Mangrove Partners | 280,689 | – | – | +280,689 | New |
| Boothbay Fund Management, LLC | 470,000 | – | – | 00.0% | Unchanged |